CVE-2018-14786
CVE-2018-14786 Vulnerability Analysis & Exploit Intelligence
Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulnerability where the software does not perform authentication for functionality that requires a provable user identity, where it may allow a remote attacker to gain unauthorized access to various Alaris Syringe pumps and impact the intended operation of the pump when it is connected to a terminal server via the serial port.
Published Updated Sources: cvelistV5, icscert
Triage
Is it exploited, how likely is exploitation, what does it touch, and how severe do the scoring sources call it.
Exploitation
Unreported
no source claims exploitation
EPSS
3%
chance of exploitation in 30 days
CVSS base
Unscored
no source published a base score
Affected scope
The catalog records vendors and products as separate lists, not pairs, so which product belongs to which vendor is not something this page can say.
Vendors (1)
Products (1)
Weakness & attack patterns
- CWE-287
Attack patterns reported against this CVE. The ATT&CK techniques below are inferred from its weakness class.
- T1548Abuse Elevation Control Mechanism
- T1040Network Sniffing
- T1185Browser Session Hijacking
References
3 on the record
- www.securityfocus.com/bid/105147
vdb-entry, x_refsource_BID
- www.bd.com/en-us/support/product-security-and-privacy/product-security-bulletin-for-various-alaris-plus-syringe-pumps-sold-and-in-use-outside-the-united-states
x_refsource_CONFIRM
- ics-cert.us-cert.gov/advisories/ICSMA-18-235-01
x_refsource_MISC
Elsewhere on this site
- becton dickinson andevery CVE for this vendor
- CWE-287other pages naming this weakness
Not in any source we poll
Listed rather than left blank: an empty field and an unmeasured one look identical on screen, and only one is a reason to look elsewhere.
- No confirmed IOCs, IP addresses, domains, file hashes, or malware artifacts supplied.
- No organization-specific asset inventory, compensating-control status, or patch deployment evidence supplied.
- No exploit packet captures, log samples, or incident case IDs supplied.